AzTrials
AzTrials

Spastic DiplegiaPhase 2NCT00004751

Phase II Randomized Study of Selective Dorsal Rhizotomy and Physiotherapy Vs Physiotherapy Alone for Spastic Diplegia

A Phase 2 study testing Surgery and Physical therapy in people with Spastic Diplegia, run by National Institute of Neurological Disorders and Stroke (NINDS).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

OBJECTIVES: I. Assess the efficacy and safety of selective dorsal rhizotomy and physiotherapy compared with physiotherapy alone in improving gross motor function and reducing spasticity in children with spastic diplegia. Read more about this study

Who is it for?
Ages 3 to 18 years
Conditions the study is for
Spastic Diplegia
What is being tested?
Surgery and Physical therapy
Type of treatment
Surgery or procedure
How many people
Not given
Where
No sites listed yet
Study dates
Oct 1991to not given
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

PROTOCOL ENTRY CRITERIA:

--Disease Characteristics--

  • Spastic diplegia, i.e.: Measurable spasticity with more lower than upper limb involvement
  • Fair to good trunk and head control
  • Little or no bulbar involvement
  • Able to walk or has potential to walk indoors with assistive devices
  • No fixed musculoskeletal deformity greater than 15 degrees
  • Prior orthopedic surgery acceptable if spastic muscle group is in physiologic biomechanical position and retains voluntary power
  • No detectable athetosis, rigidity, ataxia, or other movement disorder
  • No disease-related, treatable condition that may become urgent during study, e.g., hip subluxation requiring adductor release

--Patient Characteristics--

  • Age: 3 to 18
  • Other: Intelligence Quotient greater than 50 Developmental age 3 years or higher
  • Able to follow multi-step commands
  • Expressive communication skills at 3-year level or higher
  • Mild dysarthria or drooling does not exclude
  • Stable social environment
  • Regular school and physical therapy attendance
  • Normal psychiatric status
  • Guardian able to give support and follow-up care
  • No medical contraindication to anesthesia or surgery, e.g.: Previous anesthesia reaction
  • Chronic lung disease
  • Uncontrollable seizures
  • Scoliosis Vertebral anomaly
  • Neural tube defect
  • No visual impairment sufficient to hinder mobility
  • Able to come to Children's Hospital and Medical Center for follow-up Insurance coverage adequate for surgery and postoperative physiotherapy

About this study

OBJECTIVES:

  1. Assess the efficacy and safety of selective dorsal rhizotomy and physiotherapy compared with physiotherapy alone in improving gross motor function and reducing spasticity in children with spastic diplegia.
Read the detailed description

PROTOCOL OUTLINE: This is a randomized study. Patients are stratified by age and the ability to ambulate 50 feet unaided. Each stratum is block randomized.

Patients are randomly assigned to surgery plus intensive physical therapy versus intensive physical therapy alone.

The surgical procedure is a selective dorsal rhizotomy. Physical therapy (PT) includes passive and active range of motion, facilitation of isolated muscle control, transitional movements, strengthening, transfer skills, and gait training. The PT schedule is 2-hour sessions 5 days a week for 1 month, 1-hour sessions 5 days a week for 5 months, then a standard therapy program for the remainder of the study (total of 6 months). Parents supervise exercise on non-PT days.

Patients are followed at 6, 12, and 24 months.

Being tested
Surgery, Physical therapy
Keywords
cerebral palsy, neurologic and psychiatric disorders, rare disease, spastic diplegia
Medical subject headings
Cerebral Palsy, Neurologic Manifestations, Mental Disorders, Rare Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2000 (estimated)
  2. Study startOct 1991

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
IDs, dates and publications
ClinicalTrials.gov ID
NCT00004751
Sponsor's protocol ID
199/11667
Other IDs
CHS-01699211
Status last verified
Feb 1997
First submitted
24 Feb 2000
Last updated
24 Jun 2005
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Surgery and Physical therapy in people with Spastic Diplegia, run by National Institute of Neurological Disorders and Stroke (NINDS).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Jun 2005. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2005.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in